A new breast cancer treatment, gemcitabine with paclitaxel, has been shown to extend overall survival in women with advanced breast cancer. The study found that median overall survival was 18.5 months for the combination therapy, compared to 15.8 months for paclitaxel alone.
Women's lungs are more damaged by cigarette smoke, leading to a different treatment response and outcomes. Research funding is needed to understand the causes of this disparity in lung cancer incidence among women.
Loyola Medicine is conducting a clinical trial testing a new oxygen-carrying blood substitute for trauma patients. The study aims to compare the survival rate of patients receiving the blood substitute with those receiving saline solution. Community outreach efforts have been made to inform the public about the trial.
A new disc replacement device has shown promise in relieving neck pain and restoring mobility, according to a recent study. The device simulates the function of a natural cervical disc and allows patients to move their head up and down and from side to side without significant limitations.
A recent study found that efalizumab, a new biologic drug, significantly improves psoriasis symptoms and quality of life for adult patients. The treatment reduced the frequency and severity of itching and scaling, offering a potential breakthrough for those suffering from this chronic skin condition.